Abstract:Background Systemic lupus erythematosus (SLE) is a complex autoimmune disorder characterized by relapsing-remitting immune system activation, affecting multiple organ systems. Despite significant advances in understanding SLE's pathogenesis, there remains a need for comprehensive clinical profiling at the time of diagnosis to improve early detection and management. This study addresses this gap by providing a detailed analysis of the clinical presentation, disease activity, and patient outcomes using the Systemic Lupus International Collaborating Clinics (SLICC) criteria and Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) index. Methodology This cross-sectional observational study included 80 patients diagnosed with SLE using the 2012 SLICC criteria. Patients were recruited from the Rheumatology department and other wards of Byramjee Jeejeebhoy Government Medical College and Sassoon General Hospital, Pune, India. All participants provided informed consent and institutional ethical approval was obtained. Data were collected through detailed clinical history, physical examinations, and standard tests such as chest X-rays, CBC, RFT, LFT, urine microscopy, creatine phosphokinase, ANA, AntiDsDNA, complement consumption, and Coombs' tests, with 2D echocardiography performed as needed. Follow-ups every three months over 1.5 years assessed disease activity using SLEDAI criteria. Patients aged 12 and above who met the SLICC criteria were included and those with other connective tissue disorders were excluded. Associations between clinical symptoms and organ involvement were analyzed using the chi-square test with a p-value of <0.05 considered significant. Results The study evaluated 80 patients with SLE, revealing a predominantly female cohort (80%) with a mean age of 29.4 years and a standard deviation of 8.3 years, skewed towards younger age groups. Clinical manifestations were diverse; the most common symptoms were (83.75%), oral ulcers (98.75%), and alopecia (95%). Anemia (66.25%) was the most prevalent abnormality, followed by albuminuria and renal abnormalities. Organ involvement was highest in the renal system (50%) and mucocutaneous features, with lower incidences in cardiac, gastrointestinal, and vascular systems. Gender-specific analyses indicated significant differences in SLE nephritis (p=0.048) and autoimmune hemolytic anemia (p=0.046). Autoantibody profiles showed high positivity for ANA (98.8%) and DsDNA (61.3%). Clinical outcomes demonstrated that 68.8% of patients achieved remission and 16.3% experienced organ damage. The SLEDAI scores significantly improved over time, with substantial reductions from baseline to nine months (p<0.001). Conclusion In conclusion, this study provides a detailed examination of SLE, revealing that it predominantly affects young adults and is characterized by diverse manifestations including mucocutaneous symptoms, significant renal involvement, and notable autoantibody profiles. The high prevalence of anti-nucleosome and anti-dsDNA antibodies underscores their diagnostic and prognostic value. Clinically, the findings highlight the necessity for early detection and targeted management of SLE, particularly in addressing renal and mucocutaneous symptoms. Future research should focus on longitudinal studies to track disease progression, explore genetic and environmental influences, and investigate regional variations to enhance treatment strategies and patient outcomes.

Childhood adverse experiences and clinical manifestations in women with systemic lupus erythematosus

Relationship between clinical manifestations and serological profile in patients affected by Systemic Lupus Erythematosus

[Clinical Manifestations of Patients with Systemic Lupus Erythematosus and Coronary Artery Disease].

Systemic lupus erythematosus in children and adults: A retrospective study in Brazilian patients

[Epidemiological, clinical, and biochemical characteristics of patients in the LUPUS-IMMex cohort]

Evaluation of depressive and anxiety symptoms in childhood-onset systemic lupus erythematosus: Frequency, course, and associated risk factors

Differences in clinical features observed between childhood-onset versus adult-onset systemic lupus erythematosus: A systematic review and meta-analysis

Clinical outcomes and predictors of maternal and fetal complications in pregnancies of patients with systemic lupus erythematosus

Impact of intimate partner violence on quality of life and disease activity in women with systemic lupus erythematosus

Clinical Profile and Outcomes of Patients With Systemic Lupus Erythematosus

Increased Adhesion Molecule Levels in Systemic Lupus Erythematosus: Relationships with Severity of Illness, Autoimmunity, Metabolic Syndrome and Cortisol Levels

Association between academic performance and cognitive dysfunction in patients with juvenile systemic lupus erythematosus

Adolescent health care needs and relationship to disease in patients with childhood‐onset systemic lupus erythematosus

458 Increased Adhesion Molecule Levels in Systemic Lupus Erythematosus: Relationships with Severity of Illness, Autoimmunity and Cortisol Levels

Chronic kidney disease in patients with childhood-onset systemic lupus erythematosus

Positive psychosocial factors may protect against perceived stress in people with systemic lupus erythematosus with and without trauma history

Clinical phenotype and outcome in lupus according to age: a comparison between juvenile and adult onset

Learning from serum markers reflecting endothelial activation: longitudinal data in childhood-onset systemic lupus erythematosus

Cardiac Manifestations in Systemic Lupus Erythematosus: Clinical Correlates of Subclinical Echocardiographic Features

Impact of sex disparities on the clinical manifestations in patients with systemic lupus erythematosus: A systematic review and meta-analysis

Sex differences in clinical presentation of systemic lupus erythematosus